Bristol-Myers Squibb Company (BMY) Management Presents at Leerink Partners Global Biopharma Conference 2024 Conference (Transcript)Seeking Alpha • 03/13/24
Bristol-Myers Squibb Company (BMY) 44th Annual TD Cowen Healthcare Conference (Transcript)Seeking Alpha • 03/04/24
Bristol-Myers Squibb Company (BMY) Management presents at Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript)Seeking Alpha • 01/04/24
BRISTOL MYERS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMYPRNewsWire • 11/24/21
BRISTOL MYERS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMYPRNewsWire • 11/18/21
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bristol-Myers Squibb Company and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 11/01/21
Investor Alert: Class Action Lawsuit Filed Against Bristol-Myers Squibb CompanyNewsfile Corp • 10/28/21
CELG Investor Alert: Class Action Lawsuit Filed Against Bristol-Myers Squibb CompanyNewsfile Corp • 10/23/21
Entwistle & Cappucci LLP Files a Securities Class Action Complaint Against Bristol-Myers Squibb CompanyBusiness Wire • 10/06/21
How Gilead Sciences Is Helping Fund Bristol-Myers Squibb's Celgene AcquisitionThe Motley Fool • 12/21/19
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?The Motley Fool • 12/16/19
Biotech Stocks Burn A Hole In Big Pharma's Pocket. Look For More In 2020Investors Business Daily • 12/13/19